Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Aequus Pharmaceuticals Inc (AQS.VN)

Aequus Pharmaceuticals Inc (AQS.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Press Release for Early Warning Report Regarding Aequus Pharmaceuticals Inc. Globe Newswire - Fri Jul 22, 2022

VANCOUVER, British Columbia, July 23, 2022 (GLOBE NEWSWIRE) -- Doug Janzen, of 2820 – 200 Granville St., Vancouver, BC, V6C 1S4, today announced that on...

AQS.VN : 0.015 (unch)
AQSZF : 0.0094 (-25.98%)
Aequus Resumes Trading on TSX Venture Exchange Globe Newswire - Wed Jul 13, 2022

VANCOUVER, British Columbia, July 13, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) announces that further to our news...

AQS.VN : 0.015 (unch)
AQSZF : 0.0094 (-25.98%)
Aequus Signs Exclusive Distribution Agreement with SCOPE Ophthalmics for Canadian Distribution Rights of Dry Eye Products Globe Newswire - Wed Jul 6, 2022

VANCOUVER, British Columbia, July 06, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”) is...

AQS.VN : 0.015 (unch)
AQSZF : 0.0094 (-25.98%)
Aequus Provides General Update and Reports Record 2021 Financial Results Globe Newswire - Fri Jul 1, 2022

Also reports Financial Results for the 3 months ended March 31, 2022 VANCOUVER, British Columbia, July 01, 2022 (GLOBE NEWSWIRE) -- Aequus...

AQS.VN : 0.015 (unch)
AQSZF : 0.0094 (-25.98%)
Aequus Provides Update on Delay in Filing Annual Financial Statements Globe Newswire - Mon Jun 13, 2022

VANCOUVER, British Columbia, June 13, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”)...

AQS.VN : 0.015 (unch)
AQSZF : 0.0094 (-25.98%)
Aequus Provides Update on Delay in Filing Annual Financial Statements Globe Newswire - Fri May 27, 2022

VANCOUVER, British Columbia, May 27, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”)...

AQS.VN : 0.015 (unch)
AQSZF : 0.0094 (-25.98%)
Aequus Provides Update on Delay in Filing Annual Financial Statements Globe Newswire - Fri May 6, 2022

VANCOUVER, British Columbia, May 06, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”)...

AQS.VN : 0.015 (unch)
AQSZF : 0.0094 (-25.98%)
Aequus Announces Delay in Filing Annual Financial Statements Globe Newswire - Mon May 2, 2022

VANCOUVER, British Columbia, May 02, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”)...

AQS.VN : 0.015 (unch)
AQSZF : 0.0094 (-25.98%)
Aequus Announces Short Term Loan Globe Newswire - Mon May 2, 2022

VANCOUVER, British Columbia, May 02, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”)...

AQS.VN : 0.015 (unch)
AQSZF : 0.0094 (-25.98%)
Aequus Announces Director Resignation Globe Newswire - Fri Apr 22, 2022

VANCOUVER, British Columbia, April 22, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), a specialty pharmaceutical...

AQS.VN : 0.015 (unch)
AQSZF : 0.0094 (-25.98%)

Barchart Exclusives

Bottom 100 Stocks to Buy: Very Aggressive Investors Might Consider a Small Wager on This Class Action Stock Barchart - 3 minutes ago
Sonder Holdings faces a potential class action lawsuit over the handling of its financial statements in 2022 and 2023. The penny stock has lost nearly 60% of its value over the past year and is in Barchart’s Bottom 100 Stocks to Buy. Yet, it could be a moneymaker for aggressive investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot